CLINICAL_TRIALS
trial_result
· 2015-04-09
Clinical Trial Update: Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD) [Phase 1, Phase 2]
Summary
A Phase I/II study of PRO044 for Duchenne Muscular Dystrophy has completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioMarin Pharmaceutical | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-04-09